Adenocarcinoma of the lung differential diagnosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]
Overview
Adenocarcinoma of the lung must be differentiated from atypical adenomatous hyperplasia of the lung, adenocarcinoma in situ, squamous cell carcinoma of the lung, small cell carcinoma of the lung, malignant mesothelioma, and metastatic adenocarcinoma.
Differentiating Adenocarcinoma of the Lung from other Diseases
Adenocarcinoma of the lung must be differentiated from:[1]
- Atypical adenomatous hyperplasia of the lung
- Adenocarcinoma in situ
- Squamous cell carcinoma of the lung
- Small cell carcinoma of the lung
- Malignant mesothelioma
- Metastatic adenocarcinoma
- Colorectal adenocarcinoma
- Breast adenocarcinoma
- Invasive ductal carcinoma of the breast
- Invasive lobular carcinoma
- Amyloidosis
- Pulmonary tuberculosis
- Non-Hodgkin's lymphoma (NHL)
- Hodgkin's lymphoma
- Thymoma
- Tracheal tumors
- Thyroid mass
- Arteriovenous malformation
- Wegener's granulomatosis
- Sarcoidosis
- Lung abscess[2]
- Pneumonia
- Fungal infection
- Chronic eosinophilic pneumonia[3]
Differentiating Lung Cancer from Other Diseases
Lung cancer must be differentiated from other cavitary lung lesions. The table below summarizes the differentiation:
Causes of
lung cavities |
Differentiating Features | Differentiating radiological findings | Diagnosis
confirmation |
---|---|---|---|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
||
|
|
| |
|
|
|
The following table summarizes the differentiation of various lung tumors based on histological and topographical features:[17]
Abrevations:
HPV: human papillomavirus; CEA: Carcino embryogenic antigen; TTF1: Thyroid transcription factor-1; EMA: Epithelial membrane antigen; CK: Cyto keratin; CD: Cluster differentiation; NCAM: Neural Cell Differentiation Molecule; MMP's: Mettaloprotineases matrix ; GFAP: Glial fibrocilliary acid protein | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Benign Lung Tumors[18] | ||||||||||
Benign lung tumor | Risk/Epidemiology | Pleuripotent cells | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Papilloma[19] | Squamous cell papilloma |
|
|
|
|
|
| |||
Glandular papilloma |
|
|
|
|
|
|
| |||
Adenoma[20] | Alveolar adenoma |
|
|
|
|
|
|
| ||
Papillary adenoma[21] |
|
|
|
|
|
|
|
| ||
Mucinous cystadenoma |
|
|
|
|
|
|
|
| ||
Malignant Lung Tumors[22] | ||||||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Squamous cell carcinoma (SCC)[23] | Papillary |
|
|
|
|
|
|
|||
Clear cell |
| |||||||||
Basaloid |
| |||||||||
Small cell carcinoma[24] |
|
|
|
|
|
| ||||
Adenocarcinoma[25][26][27] | Acinar adenocarcinoma |
|
|
|
|
|
Aerogenous spread is characteristic
| |||
Papillary adenocarcinoma |
| |||||||||
Bronchio-alveolar carcinoma | Non-mucinous | |||||||||
Mucinous |
| |||||||||
Mixed non-mucinous and mucinous or indeterminate |
| |||||||||
Solid adenocarcinoma with mucin production | Fetal adenocarcinoma |
| ||||||||
Mucinous (“colloid”) carcinoma |
| |||||||||
Mucinous cystadenocarcinoma |
| |||||||||
Signet ring adenocarcinoma |
| |||||||||
Clear cell adenocarcinoma |
| |||||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Large cell carcinoma[28] | Basaloid large cell carcinoma of the lung |
|
|
|
|
|
|
| ||
Clear cell carcinoma of the lung | ||||||||||
Lymphoepithelioma-like carcinoma of the lung |
| |||||||||
Large-cell lung carcinoma with rhabdoid phenotype |
| |||||||||
Mixed type |
| |||||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Sarcomatoid carcinoma[29] | Carcinosarcoma |
|
|
|
|
|
|
|||
Spindle cell carcinoma |
|
|||||||||
Giant cell carcinoma |
| |||||||||
Pleomorphic carcinoma |
| |||||||||
Pulmonary blastoma |
|
| ||||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Carcinoid tumor[30] | Typical carcinoid
Atypical carcinoid |
|
|
|
|
|
|
|||
Salivary gland tumors[31] | Mucoepidermoid carcinoma |
|
|
|
|
|
|
| ||
Adenoid cystic carcinoma |
|
|
|
|
|
|||||
Epithelial-myoepithelial carcinoma |
|
|
|
|
|
|||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Preinvasive lesions[32] | Squamous carcinoma in situ |
|
|
|
|
|
||||
Atypical adenomatous hyperplasia |
|
|
|
|
| |||||
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia |
|
|
|
| ||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Mesenchymal tumors[33] | Epithelioid haemangioendothelioma / Angiosarcoma |
|
|
|
|
|
||||
Pleuropulmonary blastoma |
|
|
|
|
|
|||||
Chondroma |
|
|
|
|
|
|
|
| ||
Congenital peribronchial myofibroblastic tumor |
|
|
|
|
|
| ||||
Diffuse pulmonary lymphangiomatosis |
|
|
|
|
|
| ||||
Inflammatory myofibroblastic tumor |
|
|
|
|
|
| ||||
Pulmonary artery sarcoma |
|
|
|
|
|
|
| |||
Pulmonary vein sarcoma |
|
|
|
|
The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.[4][5][7][34][15]
Disease | Clinical features
Signs & symptoms |
Radiological Findings | Characterstic feature | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Cough | Hemoptysis | Dyspnea | Chest pain | Weight loss | Night sweats | |||||
High-grade | Low grade | Productive | Dry | ||||||||
Acute Lung abscess | + | - | + | - | - | - | + | - | - |
|
|
Malignancy | - | + | - | + | + | - | - | + | + |
|
|
Pulmonary Tuberculosis | + | - | + | - | + | - | - | - | + |
|
|
Necrotizing Pneumonia | + | - | + | + | - | + | - | - |
|
| |
Empyema | + | - | + | - | + | + | + | - | - |
|
|
Bronchiectasis | - | - | + | - | + | - | - | - | - |
|
|
Wegners granulomatosis | - | - | + | + | + | - | - | - |
| ||
Sarcoidosis | + | - | + | - | + | - | - | + | + |
|
|
Rheumatoid nodule | - | - | - | - | - | + | - | + | - |
|
|
Langerhans cell Histiocytosis | - | - | - | - | - | + | + | + | - |
|
|
Bronchiolitis obliterans | - | - | + | - | + | + | + | - | - |
|
|
References
- ↑ Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/Adenocarcinoma_of_the_lung
- ↑ Kamiya K, Yoshizu A, Misumi Y, Hida N, Okamoto H, Yoshida S (2011). "[Lung abscess which needed to be distinguished from lung cancer; report of a case]". Kyobu Geka. 64 (13): 1204–7. PMID 22242302.
- ↑ Matsuoka T, Uematsu H, Iwakiri S, Itoi K (2013). "[Chronic eosinophilic pneumonia presenting as a solitary nodule, suspicious of lung cancer;report of a case]". Kyobu Geka. 66 (10): 941–3. PMID 24008649.
- ↑ 4.0 4.1 4.2 Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
- ↑ 5.0 5.1 Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
- ↑ Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM (2005). "Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome". Radiology. 237 (1): 342–7. doi:10.1148/radiol.2371041650. PMID 16183941.
- ↑ 7.0 7.1 7.2 Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
- ↑ Lee KS, Kim TS, Fujimoto K, Moriya H, Watanabe H, Tateishi U, Ashizawa K, Johkoh T, Kim EA, Kwon OJ (2003). "Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients". Eur Radiol. 13 (1): 43–51. doi:10.1007/s00330-002-1422-2. PMID 12541109.
- ↑ Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R (2001). "Clinical characteristics of patients in a case control study of sarcoidosis". Am. J. Respir. Crit. Care Med. 164 (10 Pt 1): 1885–9. doi:10.1164/ajrccm.164.10.2104046. PMID 11734441.
- ↑ Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H (1989). "Pulmonary sarcoidosis: evaluation with high-resolution CT". Radiology. 172 (2): 467–71. doi:10.1148/radiology.172.2.2748828. PMID 2748828.
- ↑ Murphy J, Schnyder P, Herold C, Flower C (1998). "Bronchiolitis obliterans organising pneumonia simulating bronchial carcinoma". Eur Radiol. 8 (7): 1165–9. doi:10.1007/s003300050527. PMID 9724431.
- ↑ 12.0 12.1 Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN (2008). "Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review". Ann Thorac Med. 3 (2): 67–75. doi:10.4103/1817-1737.39641. PMC 2700454. PMID 19561910.
- ↑ Cordier JF, Loire R, Brune J (1989). "Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients". Chest. 96 (5): 999–1004. PMID 2805873.
- ↑ Lee KS, Kullnig P, Hartman TE, Müller NL (1994). "Cryptogenic organizing pneumonia: CT findings in 43 patients". AJR Am J Roentgenol. 162 (3): 543–6. doi:10.2214/ajr.162.3.8109493. PMID 8109493.
- ↑ 15.0 15.1 Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.
- ↑ Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR (1989). "Pulmonary histiocytosis X: comparison of radiographic and CT findings". Radiology. 172 (1): 249–54. doi:10.1148/radiology.172.1.2787035. PMID 2787035.
- ↑ Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000). "Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions". Radiographics. 20 (1): 43–58. doi:10.1148/radiographics.20.1.g00ja0343. PMID 10682770.
- ↑ Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK (June 2012). "Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging". Radiol Oncol. 46 (2): 106–13. doi:10.2478/v10019-012-0021-3. PMC 3472932. PMID 23077446.
- ↑ Maxwell RJ, Gibbons JR, O'Hara MD (January 1985). "Solitary squamous papilloma of the bronchus". Thorax. 40 (1): 68–71. PMC 459982. PMID 3969658.
- ↑ Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K (1998). "Solitary bronchioloalveolar adenoma of the lung". Respiration. 65 (6): 483–5. doi:10.1159/000029319. PMID 9817965.
- ↑ Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D (March 2017). "A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung". Cureus. 9 (3): e1069. doi:10.7759/cureus.1069. PMC 5375953. PMID 28409070.
- ↑ Kelley LC, Puette M, Langheinrich KA, King B (November 1994). "Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry". Vet. Pathol. 31 (6): 658–62. doi:10.1177/030098589403100605. PMID 7863581.
- ↑ Roth E, Smidt D (January 1970). "[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs]". Berl. Munch. Tierarztl. Wochenschr. (in German). 83 (1): 7–11. PMID 5528918.
- ↑ Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
- ↑ Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson. "Chapter 13, box on morphology of adenocarcinoma". Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
- ↑ Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S; et al. (2007). "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer". Nature. 448 (7153): 561–6. doi:10.1038/nature05945. PMID 17625570.
- ↑ Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg
- ↑ Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (January 2014). "Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology". Virchows Arch. 464 (1): 61–8. doi:10.1007/s00428-013-1501-6. PMID 24221342.
- ↑ Huang SY, Shen SJ, Li XY (October 2013). "Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases". World J Surg Oncol. 11: 252. doi:10.1186/1477-7819-11-252. PMC 3850921. PMID 24088577.
- ↑ Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S (March 2009). "Lung carcinoid tumor biology: treatment and survival". Oncol. Rep. 21 (3): 757–60. PMID 19212636.
- ↑ Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM (July 2013). "Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome". AJR Am J Roentgenol. 201 (1): W57–63. doi:10.2214/AJR.12.9579. PMC 3767141. PMID 23789697.
- ↑ Greenberg AK, Yee H, Rom WN (2002). "Preneoplastic lesions of the lung". Respir. Res. 3: 20. PMC 107849. PMID 11980589.
- ↑ Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP (April 2014). "Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms". Insights Imaging. 5 (2): 237–44. doi:10.1007/s13244-013-0306-0. PMC 3999366. PMID 24407922.
- ↑ Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.